Here's YTD M&A league tables from Thomson Reuters/Refinitiv.

Edit: Since the picture isn't showing up:

1. Goldman Sachs - $412.0 bn, 131 Deals

2. JP Morgan - $250.6 bn, 94 Deals

3. Morgan Stanley - $221.3 bn, 97 Deals

4. BofA - $197.4 bn, 69 Deals

5. Citi - $182.5 bn, 52 Deals

6. Barclays - $119.7 bn, 66 Deals

7. Credit Suisse - $116.2 bn, 39 Deals

8. Jefferies - $101.1 bn, 71 Deals

9. BNP Paribas - $95.8 bn, 36 Deals

10. Lazard - $89.9 bn, 69 Deals

 

Balance sheet bank. Gets buy-side advisory credit on a number of large deals each year for providing cheap financing (large deals they got buy-side credit for providing financing that I can think of this year include the HDFC and Cornerstone deals). Almost always the buy-side advisor for their larger deals, and usually not the sole bank (because they are mainly just there to provide financing while another bank does the advisory).

 

Interesting that Dealogic seems to miss some pretty big deals in its count, most notably HDFC Bank's $60 bn acquisition of Housing Development Finance Corp.

 

From Thomson Reuters/Refinitiv. Obviously not perfect (some deals are classed incorrectly, and had to manually de-select gaming and media & telecom), but a solid approximation :

1. JP Morgan - $17.7 bn, 12 Deals

2. GS - $16.7 bn, 10 Deals

3. Citi - $14.0 bn, 7 Deals

4. Jefferies - $11.9 bn, 4 Deals

5. BofA - $10.7 bn, 10 Deals

6. Rothschild - $9.2 bn, 16 Deals

7. MS - $6.2 bn, 9 Deals

8. Evercore - $3.6 bn, 5 Deals

9. Barclays - $3.6 bn, 9 Deals

10. Arctic Securities - $3.2 bn, 1 Deal

 

From Thomson Reuters for TMT:

1. GS - $165.1 bn, 42 Deals

2. Allen & Co - $84.5 bn, 3 Deals

3. JP Morgan - $55.8 bn, 25 Deals

4. Citi - $38.4 bn, 5 Deals

5. BofA - $37.5 bn, 11 Deals

6. Barclays - $36.5 bn, 9 Deals

7. MS - $35.9 bn, 22 Deals

8. CS - $33.4 bn, 7 Deals

9. Qatalyst - $27.6 bn, 3 Deals

10. PJT Partners - $20.8 bn, 9 Deals

GS dominating the TMT space as per usual.

 

From the poster below: 
 

League tables don't include HCIT, which are usually classified under Technology, so the league tables for HC are more like BioTech + HC Services + Med Devices.

1. SVB Leerink - $8.6 bn, 4 Deals

2. Jefferies - $7.9 bn, 14 Deals

3. Citi - $6.1 bn, 5 Deals

4. JP Morgan - $4.0 bn, 8 Deals

5. Lazard - $4.0 bn, 11 Deals

6. Evercore - $3.6 bn, 4 Deals

7. Moelis - $3.5 bn, 6 Deals

8. Allegro Capital Advisors - $3.3 bn, 1 Deal

8. PJT Partners - $3.3 bn, 1 Deal

10. GS - $3.2 bn, 10 Deals

SVBL and Jefferies leading the pack, SVB with a fast start in BioTech and Jefferies doing their usual thing in HC Services and BioTech, and both landing the LHC/Optum deal. Also, not reflected in the top 10 league tables are MS executing a bunch of services & biotech deals with undisclosed values (Over a dozen deals to date), and HL and Rothschild doing quite some volume in the MM space.

 
Most Helpful

From Factset, which tends to miss quite a number of deals. Also should note that O&G league tables aren't the best because a lot of sizable O&G deals A&D deals are undisclosed and aren't included (which are Rothschild and JEF especially do quite a lot of):

1. RBC - $10.5 bn, 10 Deals

2. Citigroup - $5.7 bn, 3 Deals

3. Jefferies - $3.6 bn, 5 Deals

4. PWP/TPH - $3.6 bn, 3 Deals

5. GS - $3.5 bn, 1 Deal

6. JP Morgan - $2.6 bn, 1 Deal

7. Scotiabank - $1.6 bn, 1 Deal

8. PJT Partners - $1.3 bn, 1 Deal

9. WF - $960 mm, 2 Deals

10. Johnson Rice & Co, $860 mm, 1 Deal

Overall basically what you'd expect. RBC shows its lending prowess and relationships, with 7 of its 10 deals being buy-side deals; Citi is overall strong in O&G. Jefferies is killing it in A&D (can confirm that Factset misses a number of those transactions), and PWP/TPH has made a comeback despite concerns over losing some top seniors.

 

Surprised that EVR is missing. What’s going on there?

Also noticed that GS/ JPM are below Citi/Jeff/TPH in league tables right now.

 

From Thomson Reuters. Keep in mind that many RX deals are undisclosed and YTD 2022 RX activity has been pretty muted.

1. Moelis - $77.7 bn, 7 Deals

2. PJT Partners - $59.6 bn, 5 Deals

3. Lazard - $58.4 bn, 5 Deals

4. HL - $53.4 bn, 7 Deals

5. Rothschild - $38.2 bn, 3 Deals

6. Ankura Consulting Group - $35 bn, 1 Deal

7. Greenhill - $35 bn, 1 Deal

8. AlixPartners - $19.0 bn, 3 Deals

9. FTI Consulting - $17.4 bn, 2 Deals

10. Evercore - $9.7 bn, 2 Deals

 

from my understanding, RX league tables can be misleading in a way that is similar to how m&a league tables can be misleading: balance sheet banks get m&a credit for facilitating financing - one RX deal can have multiple shops repping debtor & different classes of creditors, so don’t think the tables are super indicative (+ the many undisclosed RX deals)

 

are 8 and 9 their actual IB divisions or their normal consulting divisions.

 

Anyone have just Tech league tables (excluding media & telecom)? Thanks!

 

From Thomson Reuters, any Canadian involvement:

1. MS - $20.4 bn, 13 Deals

2. JPM - $18.5 bn, 5 Deals

3. TD - $16.6 bn, 8 Deals

4. Goldman Sachs - $10.8 bn, 8 Deals

5. Lazard - $9.9 bn, 9 Deals

6. RBC - $9.4 bn, 17 Deals

7. Credit Suisse - $7.2 bn, 5 Deals

8. Barclays - $5.7 bn, 4 Deals

9. CIBC - $5.4 bn, 8 Deals

10. PJT - $4.4 bn, 2 Deals

Basically no surprises, except for maybe the fact that BMO isn't in the top 10, but the year is still early.

 

League tables don't include HCIT, which are usually classified under Technology, so the league tables for HC are more like BioTech + HC Services + Med Devices.

1. SVB Leerink - $8.6 bn, 4 Deals

2. Jefferies - $7.9 bn, 14 Deals

3. Citi - $6.1 bn, 5 Deals

4. JP Morgan - $4.0 bn, 8 Deals

5. Lazard - $4.0 bn, 11 Deals

6. Evercore - $3.6 bn, 4 Deals

7. Moelis - $3.5 bn, 6 Deals

8. Allegro Capital Advisors - $3.3 bn, 1 Deal

8. PJT Partners - $3.3 bn, 1 Deal

10. GS - $3.2 bn, 10 Deals

SVBL and Jefferies leading the pack, SVB with a fast start in BioTech and Jefferies doing their usual thing in HC Services and BioTech, and both landing the LHC/Optum deal. Also, not reflected in the top 10 league tables are MS executing a bunch of services & biotech deals with undisclosed values (Over a dozen deals to date), and HL and Rothschild doing quite some volume in the MM space.

 
[Comment removed by mod team]
 

From Thomson Reuters, YTD 4/05/2021 league tables last year:

1. GS - $374.1 bn, 169 Deals

2. JP Morgan - $292.2 bn, 164 Deals

3. MS - $227.7 bn, 109 Deals

4. Citi - $223.3 bn, 100 Deals

5. BofA - $197.3 bn, 84 Deals

6. Barclays - $156.1 bn, 80 Deals

7. CS - $139.0 bn, 72 Deals

8. Evercore - $121.4 bn, 50 Deals

9. Lazard - $73.8 bn, 65 Deals

10. DB - $57.4 bn, 39 Deals

11. UBS - $57.2 bn, 51 Deals

12. Jefferies - $54.5 bn, 86 Deals

13. PJT - $54.2 bn, 20 Deals

14. BMO - $50 bn, 15 Deals

15. CVP - $42.6 bn, 24 Deals

Industry Total of $1.3 trillion compared with $1.1 trillion in transaction volume YTD 2022.

 

Lack of marquee transactions. By this point last year their announced deals include the $31 bn AerCap/GE deal, the $31 bn Canadian Pacific/Kansas City Southern deal, and the $8 bn Teledyne/FLIR Deal, and by this point in 2020 they had completed the $24.5 bn Otis Elevator spin-off, the $21 bn UTC spin-off, and the $11 bn Equitrans Midstream/EQM deal. Largest deal so far this year was the $9 bn TEGNA deal, and most of their announced deals have been mid-cap to UMM-sized deals.

 

1. JPM - $105.5 bn, 14 Deals

2. GS - $102.0 bn, 21 Deals

3. MS - $87.7 bn, 11 Deals

4. BofA - $79.0 bn, 14 Deals

5. Citi - $76.2 bn, 9 Deals

6. CS - $65.5 bn, 6 Deals

7. BNP Paribas - $63.5 bn, 7 Deals

8. Axis Bank - $62.6 bn, 3 Deals

9. Jefferies - $60.8 bn, 7 Deals

10. CITIC - $60.7 bn, 3 Deals

Big year for FIG with the landmark HDFC merger which half the BBs got buy-side credit for (although Jefferies and CS were the big winners from that as joint lead sell-side advisors), as well as Citi shedding their consumer bank (providing themselves with some nice deal flow lol).

 

From above:

From Factset, which tends to miss quite a number of deals. Also should note that O&G league tables aren't the best because a lot of sizable O&G deals A&D deals are undisclosed and aren't included (which are Rothschild and JEF especially do quite a lot of):

1. RBC - $10.5 bn, 10 Deals

2. Citigroup - $5.7 bn, 3 Deals

3. Jefferies - $3.6 bn, 5 Deals

4. PWP/TPH - $3.6 bn, 3 Deals

5. GS - $3.5 bn, 1 Deal

6. JP Morgan - $2.6 bn, 1 Deal

7. Scotiabank - $1.6 bn, 1 Deal

8. PJT Partners - $1.3 bn, 1 Deal

9. WF - $960 mm, 2 Deals

10. Johnson Rice & Co, $860 mm, 1 Deal

Overall basically what you'd expect. RBC shows its lending prowess and relationships, with 7 of its 10 deals being buy-side deals; Citi is overall strong in O&G. Jefferies is killing it in A&D (can confirm that Factset misses a number of those transactions), and PWP/TPH has made a comeback despite concerns over losing some top seniors.

 

Atque et eveniet maxime dolorum. Sapiente dolore cum nam.

Tenetur accusantium ducimus beatae aut qui harum repellendus. Occaecati quod iusto reprehenderit fugiat magni cumque.

 

Rem delectus quo ducimus laudantium voluptatibus natus. Et asperiores qui dignissimos omnis delectus minus aut.

Qui dicta hic facilis. Harum dicta expedita qui quo dignissimos nihil. Aliquam dolorum magni nam sunt distinctio repellat maiores.

Assumenda ratione ut quia reprehenderit. Quia dolorem sit iusto dolorem. Voluptas est quo ipsum quos perferendis. Earum repellendus et et consequatur provident eveniet natus provident. Et sint autem illo. Molestias enim explicabo quis vel.

 

Beatae ad debitis minus. Omnis suscipit iste voluptatem. Necessitatibus perspiciatis est odit facere sed odit aspernatur assumenda. Neque sunt est sunt id error atque sunt placeat. Nemo sunt molestiae sunt nihil qui. Veritatis perferendis et doloribus aut labore dolore sint. Cupiditate et officiis dolore sint nulla consequatur.

Quasi optio est est laboriosam omnis consequatur. Et consectetur praesentium sunt quos aliquid consequatur. Voluptas facilis iusto aliquam voluptatum ut non. Odit voluptatibus sit corrupti quas.

Career Advancement Opportunities

April 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Goldman Sachs 19 98.8%
  • Harris Williams & Co. New 98.3%
  • Lazard Freres 02 97.7%
  • JPMorgan Chase 03 97.1%

Overall Employee Satisfaction

April 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

April 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

April 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (19) $385
  • Associates (86) $261
  • 3rd+ Year Analyst (14) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (66) $168
  • 1st Year Analyst (205) $159
  • Intern/Summer Analyst (145) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”